The Global TB Vaccine R&D Roadmap was commissioned by the European & Developing Countries Clinical Trials Partnership (EDCTP) to the Amsterdam Institute for Global Health and Development (AIGHD) to identify priorities to coordinate global action to accelerate the development and implementation of new TB vaccines. The Roadmap has been developed through an iterative global consultative process designed to identify the key barriers to TB vaccine R&D and implementation, and potential ways in which they might be overcome. It is intended to provide a shared set of priorities to guide the activities of all stakeholders with an interest in TB vaccine development and use.AIGHD and EDCTP are pleased to invite the global TB vaccine community and interested stakeholders to attend the official launch of the Roadmap. The session opens with an introduction to the Roadmap, followed by an overview of current challenges and opportunities for TB vaccine R&D, and the perspective from a community representative. The presentations will be followed by a panel discussion with a diverse group of stakeholders, each sharing their comments on the Roadmap, their views on how they are planning to use it, and how they consider it can guide the future development of TB vaccines.
When: 20 April 2021, 18:00-19:30 CEST
Where: Virtual (Zoom)
REGISTER NOW: https://zoom.us/webinar/register/WN_pbpKgGpRR6ejZN1B-i0bxQ
The Minister of Health, South Africa, Dr Zweli Mkhize and and Dr Matshidiso Moeti, WHO Regional Director for Africa invite you to webinar on World Health Day.
Overall objective: Generate awareness about the health inequities and strengthen efforts towards more inclusive approach for Universal Health Coverage and health security in South Africa
• Impact of COVID-19 on health inequities - Professor John Ataguba
• Access to quality essential health services for all – Professor Lydia Caircncross
• Building resilient health systems – Dr Flavia Senkubuge
• National Health Insurance- the greatest social equaliser - Professor Rob van Niekerk
Date: 7 April 2021
Time: 10.00am (SA time)
Register here: https://us02web.zoom.us/webinar/register/WN_PDCSaoh6S5mpEb2MunTiFA
Read moreThe event is supported by Fogarty, International Development Research Centre (IDRC), UK Medical Research Council (MRC), and Wellcome Trust, and will serve as a pilot to help determine if there is sufficient interest in a recurring event in the future.
The event will bring researchers and humanitarian organizations together to share experiences and promote collaboration around health research in humanitarian settings, modelled after the Global Forum on Bioethics in Research (which Fogarty also supports). The target audience is early- to mid-career researchers from LMICs and countries affected by humanitarian crises, though the applications are open to all interested parties.
Applications are invited for case study presenters and general participants, with a submission deadline of May 28, 2021.
The following themes for case studies for the upcoming Global Forum on Humanitarian Health Research may be of interest (announcement below). Case studies to be presented at GFH2R should relate specifically to the theme of “Research in the Context of Concurrent Crises.” Questions that could be explored in the case studies include, but are not limited to:
• What are the key ethical considerations for researchers working in the context of multiple humanitarian crises? What are some specific ethical dilemmas in these settings?
• How can researchers better engage with communities living in humanitarian crises?
• How can research provide an opportunity for inclusion and nurture leadership of local actors in problem solving in such contexts?
• What are specific experiences and good practices related to the study of specific subpopulations (e.g. vulnerable populations, women, children, etc.)?
For more information visit https://www.fic.nih.gov/About/center-global-health-studies/Pages/health-research-humanitarian-crises-global-forum.aspx
What is mathematical epidemiology and how has it traditionally been used? What can epidemiological trends tell us and what is the importance of genomic surveillance? How can mathematical modelling support planning of COVID-19 interventions? Join us to review the history of mathematical epidemiology and modelling, its world-wide prominence over the last 12 months, and why we are discussing the science behind COVID-19 modelling and epidemiology data today. We will look at monitoring of genetic variants, communication beyond the science to decision makers, COVID-19 vaccine and intervention modelling, and how to interpret scenarios (not forecasts) for decision making.
Preliminary Programme
12:00 Setting the Scene and Interpreting Epidemiologicial Trends, Melissa Penny and Nakul Chitnis, Swiss TPH
12:25 Genomic Surveillance and Epidemiological Trends, Sarah Nadeau, Swiss Federal Institute of Technology (ETH Zürich)
12:50 Understanding Intervention Scenarios, Andrew Shattock, Swiss TPH
13:15 Q&A
13:30 End of Session
For more information and to register visit - https://www.swisstph.ch/en/about/events/ves/
Read more